A nationwide survey on current clinical practices for diagnosis and treatment of patients with BRAF-mutated melanoma and BRAF-mutated colorectal cancer in Argentina
Background: v-Raf murine sarcoma viral oncogene homolog B1 (BRAF) mutation occurs in approximately 50% of cutaneous melanoma and in 10% of patients with colorectal cancer (CRC). BRAF testing is recommended as good clinical practice, since it is critical for decision-making regarding adjuvants and treatment selection. I...